723 filings
Page 31 of 37
8-K
CDXC
Chromadex Corp
30 Aug 12
Submission of Matters to a Vote of Security Holders
12:00am
10-Q/A
2012 Q2
CDXC
Chromadex Corp
Quarterly report (amended)
10 Aug 12
12:00am
10-Q
2012 Q2
CDXC
Chromadex Corp
Quarterly report
9 Aug 12
12:00am
DEF 14A
CDXC
Chromadex Corp
Definitive proxy
27 Jul 12
12:00am
8-K
CDXC
Chromadex Corp
16 Jul 12
ChromaDex® Licenses Exclusive Patent Rights for Nicotinamide Riboside (NR) Vitamin Technologies from Dartmouth College
12:00am
SC 13D/A
CDXC
Chromadex Corp
12 Jul 12
ChromaDex / FROST PHILLIP MD ET AL ownership change
12:00am
8-K
CDXC
Chromadex Corp
12 Jun 12
ChromaDex® Corp. Names Co-founder Frank Jaksch CEO & President
12:00am
10-Q
2012 Q1
CDXC
Chromadex Corp
Quarterly report
10 May 12
12:00am
EFFECT
CDXC
Chromadex Corp
9 May 12
Notice of effectiveness
12:00am
POS AM
CDXC
Chromadex Corp
30 Apr 12
Prospectus update (post-effective amendment)
12:00am
10-K/A
2011 FY
CDXC
Chromadex Corp
Annual report (amended)
30 Apr 12
12:00am
10-K
2011 FY
CDXC
Chromadex Corp
Annual report
15 Mar 12
12:00am
8-K
CDXC
Chromadex Corp
24 Feb 12
Departure of Directors or Certain Officers
12:00am
D
CDXC
Chromadex Corp
22 Feb 12
$3.7M in equity, sold $3.7M, 12 investors
12:00am
8-K
CDXC
Chromadex Corp
17 Feb 12
ChromaDex Announces Management Changes
12:00am
8-K
CDXC
Chromadex Corp
14 Feb 12
Unregistered Sales of Equity Securities
12:00am
8-K
CDXC
Chromadex Corp
13 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
CDXC
Chromadex Corp
1 Feb 12
ChromaDex® to Raise $10.85M in Sale of Common Stock
12:00am
424B5
CDXC
Chromadex Corp
1 Feb 12
Prospectus supplement for primary offering
12:00am
8-K
CDXC
Chromadex Corp
27 Jan 12
Regulation FD Disclosure
12:00am